Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,104 recruiting studies in this area right now.
By phase
- Not applicable4,205
- Phase 2592
- Phase 1413
- Phase 3328
- Phase 4254
- Phase 1/Phase 2245
- Phase 2/Phase 367
Top conditions
- Ovarian Cancer338
- Cervical Cancer225
- Endometrial Cancer210
- Bladder Cancer188
- Acute Kidney Injury134
- Endometriosis132
- Pregnancy129
- Chronic Kidney Diseases123
- Breast Cancer112
- Chronic Kidney Disease108
- Infertility92
- Renal Cell Carcinoma80
- Colorectal Cancer78
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension60
- Urinary Incontinence59
Leading sponsors
- Mayo Clinic61
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS45
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- National Cancer Institute (NCI)41
- University of Colorado, Denver38
- AstraZeneca36
- University of Aarhus35
- Chinese University of Hong Kong34
Where studies are running
- California351
- Alabama153
- Texas119
- Massachusetts117
- New York116
- Arizona106
- Florida103
- Maryland87
- Colorado84
- Illinois79
Recruiting studies6,104 total
- NCT06334315RecruitingPhase 4
Birth control pill study for healthy women
This study looks at how genes affect the way the body processes birth control pills. You take a low-dose pill for one cycle and have blood draws to measure hormone levels.
Aurora, ColoradoAges 18–45 - NCT06333340Recruiting
Comparing two medicines to prevent heavy bleeding after planned cesarean
This study compares two medicines—carbetocin and oxytocin—given during a planned cesarean to help prevent heavy bleeding after delivery. It is for women who have certain risk factors for uterine atony (when the uterus does not tighten up after birth).
Toronto, OntarioAges 18–50 - NCT06331468RecruitingPhase 2
Short-course radiation with chemo for advanced cervical cancer
This trial tests a shorter course of radiation combined with chemotherapy (hypofractionated radiochemotherapy) for women with advanced cervical cancer. It may help reduce treatment time while still effectively targeting the tumor.
Lexington, KentuckyAges 18–120 - NCT06330480Enrolling by invitation
Screening for heart rhythm and kidney disease at home
This study is testing whether screening people at home can catch early signs of an irregular heartbeat (atrial fibrillation) and kidney disease. If you're in the right age group and live in one of the selected regions, you could join and help researchers learn more about spotting these conditions early.
AmsterdamAges 50–75 - NCT06326905Recruiting
Transplant help for kidney waitlist patients with barriers
This study helps people on the deceased donor kidney waitlist who have had setbacks like health issues, lack of support, or low income. It offers extra support to help you get ready for transplant.
Baltimore, MarylandAges 18–99 - NCT06331546Recruiting
Study of gut oxalate absorption in calcium oxalate kidney stone patients
This study looks at how your gut absorbs oxalate, a natural substance in many foods that can lead to kidney stones. By eating special diets and pausing certain supplements, researchers can measure your oxalate absorption. This may help find better ways to prevent kidney stones.
Birmingham, AlabamaAges 18–80 - NCT04478747Recruiting
Mesh versus suspension surgery for vaginal prolapse
This trial compares two surgical options to treat a type of vaginal prolapse where the top of the vagina (apical area) has dropped. It may help find which approach works better and has fewer long-term problems for people who’ve had prior prolapse surgery and a hysterectomy.
HelsinkiAges 18–99 - NCT06026592Recruiting
Detecting kidney DNA in transplant patients' blood
This study looks for small pieces of kidney DNA in the blood of kidney transplant patients. It aims to improve monitoring of transplant health.
Paris, Île-de-France RegionAges 18 years+ - NCT05941507RecruitingPhase 1/Phase 2
TROP2 antibody drug with anti–PD-1 for advanced solid tumors
This early-phase study tests an antibody-drug (an ADC) that targets TROP2, given by itself and together with an anti–PD-1 medicine. It’s for people with advanced solid cancers that have not responded to standard treatments, aiming to shrink tumors and improve control of the disease.
Los Angeles, CaliforniaAges 18 years+ - NCT06307184Recruiting
Natural cycle frozen embryo transfer convenience study
This study is testing whether starting a frozen embryo transfer during your natural cycle (after ovulation) is more convenient than the usual schedule. You will take progesterone (400 mg twice a day) and have one embryo transferred. It is for people using donor eggs who have regular cycles.
LisbonAges 18–49 - NCT06310967RecruitingPhase 1/Phase 2
Study of IG3018 for high uric acid with or without kidney disease
This trial tests a new medicine, IG3018, to lower high uric acid levels in people with or without chronic kidney disease. It aims to find the right dose and see if it's safe.
Botany, New South WalesAges 18–75 - NCT06308978RecruitingPhase 1
Study of FT819 for B-cell autoimmune diseases
This trial tests a new cell therapy, FT819, for people with certain autoimmune diseases like lupus, vasculitis, myositis, or scleroderma that haven't improved with at least two previous treatments. The goal is to see if it can help control the disease.
Beverly Hills, CaliforniaAges 12–70 - NCT06305962RecruitingEarly Phase 1
Radioactive drug for advanced PD-L1 positive solid tumors
This trial tests a radioactive medicine (177Lu-anti-PD-L1 sdAb) that delivers radiation to cancer cells with PD-L1 protein, which is found on some solid tumors. It is for people whose cancer has spread or come back after standard treatments.
Kingswood, New South WalesAges 18 years+ - NCT06312644Recruiting
Study of Ultomiris safety during pregnancy
This study looks at the safety of the medication Ultomiris when taken during pregnancy or breastfeeding. If you are pregnant and currently taking Ultomiris for an approved condition, this research will help gather information on how it affects you and your baby.
Boston, MassachusettsAges Any age - NCT06303505RecruitingPhase 1/Phase 2
TUB-040 for advanced ovarian or lung cancer after standard treatments fail
This study tests a new drug called TUB-040 for people with ovarian cancer that has stopped responding to platinum chemotherapy, or with a type of lung cancer that has returned or spread. The drug is designed to target cancer cells and deliver a powerful anti-cancer agent directly to them, potentially slowing the disease.
Birmingham, AlabamaAges 18 years+ - NCT06295965Recruiting
Blood changes and cancer therapy study
This study looks at why some people develop blood disorders after cancer treatment. It monitors changes in blood cells to better predict and prevent these problems.
Seattle, WashingtonAges Any age - NCT06299683Recruiting
Pain type and bladder pain syndrome treatment study
This study is testing if the type of pain you feel can help predict which treatments work best for interstitial cystitis (a condition that causes bladder pain and pressure). It may help match you with more effective care.
Franklin, TennesseeAges 18 years+ - NCT06305299RecruitingPhase 1
CAR-T cell therapy for ovarian cancer
This trial tests a new treatment called CAR-T cells that target a protein called B7H3 found on cancer cells. It is for people with a specific type of ovarian, peritoneal, or fallopian tube cancer that has not responded well to platinum chemotherapy or has come back quickly.
Chapel Hill, North CarolinaAges 18 years+ - NCT06315257RecruitingPhase 1
PVX7 vaccine for advanced cervical cancer
This trial tests a new immunotherapy vaccine called PVX7 for women with advanced cervical cancer that is caused by HPV. It aims to see if the vaccine can help prevent the cancer from coming back after standard treatment.
Birmingham, AlabamaAges 18 years+ - NCT06315582Recruiting
Surgery for uterine septum
This study looks at a surgical approach to remove a uterine septum (a wall of tissue inside the uterus) that is larger than 1 cm. It may help people with this condition who are between 20 and 44 years old.
Chicago, IllinoisAges 22–44 - NCT06310356Recruiting
Glucose sensor for gestational diabetes
This study tests whether a continuous glucose monitor (a small sensor that checks your blood sugar levels all day) can help women with gestational diabetes manage their blood sugar more easily. The goal is to see if it improves health for both mom and baby.
Sydney, CAMPBELLTOWN NSWAges 18 years+ - NCT06310759Recruiting
Testing urine DNA for bladder cancer detection
This trial looks at whether a large urine sample can detect bladder cancer DNA. It may help diagnose cancer without needing a cystoscopy. You can join if you are about to have a cystoscopy to check for bladder cancer.
Chicago, IllinoisAges 18–100 - NCT06311617Recruiting
Eye Blood Vessel Changes During Pregnancy
This observational study monitors changes in the blood vessels of your retina (the light-sensitive tissue at the back of the eye) during pregnancy. Researchers want to see how pregnancy affects the eyes, which might help better understand overall health.
Nashville, TennesseeAges 18 years+ - NCT06297343Recruiting
Study of blood flow risk after fistula surgery
This study looks at the risk of a lack of blood flow (ischaemia) after creating an arteriovenous fistula, which is a small surgical connection made between an artery and a vein for dialysis. The goal is to better understand how often this problem happens and what factors might increase the risk.
ParisAges 18 years+
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,104 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 9,983 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.